Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
Job J. Engel, Caspar I. van der Made, Nick Keur, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Showing 20 citing articles:

The Immune Response of OAS1, IRF9, and IFI6 Genes in the Pathogenesis of COVID-19
Malena Gajate-Arenas, Ingrid Fricke-Galindo, Omar García-Pérez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4632-4632
Open Access | Times Cited: 5
Improving hemodialysis patient depression outcomes with acupuncture: A randomized controlled trial
Xijing Yu, Shuisheng Hua, Eun Hyo Jin, et al.
Acta Psychologica (2025) Vol. 253, pp. 104728-104728
Closed Access
Differences in biomarker levels and proteomic survival prediction across two COVID-19 cohorts with distinct treatments
Cecilie Bo Hansen, Maria Elizabeth Engel Møller, Laura Pérez‐Alós, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112046-112046
Open Access
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alex Serra-Llovich, Natàlia Cullell, Olalla Maroñas, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 553-553
Open Access
Reprogramming Human Macrophages in Symptomatic Carotid Stenosis: Stabilisation of Atherosclerotic Carotid Plaques
Klaudia Kocsy, Sumeet Deshmukh, Shah Nawaz, et al.
Atherosclerosis (2025), pp. 119180-119180
Closed Access
RNA viruses, TLRs, and cytokines: the perfect storm?
Sophia K. Stegeman, Olena Kourko, Heather Amsden, et al.
Journal of Innate Immunity (2025) Vol. 17, Iss. 1, pp. 126-153
Open Access
An In Vitro Test Battery using Human Whole Blood for Immunotoxicity Hazard Identification: Proof of Concept Studies with Dexamethasone and Benzo(a)pyrene.
Victor J. Johnson, Michael I. Luster, Amber Edwards, et al.
Toxicology (2025), pp. 154153-154153
Closed Access
Deep insight into cytokine storm: from pathogenesis to treatment
Jiali Nie, Ling Zhou, Weiwei Tian, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Blood proteomics in COVID-19 infection: An update
Michal Alexovič, Tetiana Bondarchuk, Csilla Uličná, et al.
Clinica Chimica Acta (2024) Vol. 562, pp. 119881-119881
Closed Access | Times Cited: 3
Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia
José Javier Fernández, Cristina Mancebo, Sonsoles Garcinuño, et al.
Genes and Immunity (2023) Vol. 25, Iss. 1, pp. 43-54
Closed Access | Times Cited: 5
Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease
Krista E. van Meijgaarden, Suzanne van Veen, Roula Tsonaka, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19
Sarah E. Holton, Mallorie Mitchem, Hamid Chalian, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0285638-e0285638
Open Access | Times Cited: 1
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Molecular mechanisms of dexamethasone actions in COVID-19: Ion channels and airway surface liquid dynamics
Brian J. Harvey
Steroids (2023) Vol. 202, pp. 109348-109348
Open Access | Times Cited: 3
COMPLICACIONES DE LA VACUNA CHADOX1 EN PACIENTES CON ENFERMEDADES CARDIOVASCULARES: REVISIÓN BIBLIOGRÁFICA.
Darwin Daniel Campos González, Carlos Alberto Chacón Sánchez, Gloria Anabel Ortíz Cruz, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 2, pp. 2-12
Open Access
Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease
Krista E. van Meijgaarden, Suzanne van Veen, Roula Tsonaka, et al.
Research Square (Research Square) (2024)
Open Access
Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients
N. I. Voloshin, В. В. Салухов, А. А. Минаков, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 5, pp. 58-68
Open Access
Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection
Min Young Jeong, Subin Kim, Hyerim Kim, et al.
Carbohydrate Polymers (2024) Vol. 345, pp. 122546-122546
Closed Access
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19
Greg Haljan, Terry Lee, Anne McCarthy, et al.
Journal of Innate Immunity (2024) Vol. 16, Iss. 1, pp. 529-552
Closed Access
Protein Interaction Analysis and Molecular Simulation of the Anti‐Inflammatory Activities in Melaleuca cajuputi Extract Against COVID‐19
Agustyas Tjiptaningrum, Intanri Kurniati, Fadilah Fadilah, et al.
International Journal of Inflammation (2024) Vol. 2024, Iss. 1
Open Access
Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
Noemi Venditti, Giulio Petronio Petronio, Melania Pinti, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Turkish Clinicians Opinions About COVID Treatment in 2<sup>nd</sup> and 3<sup>rd</sup> Level Hospitals What Did Change from 2021 to 2022? Results of 2 Years of Follow-up
Mehmet Burak Aktuğlu
Bagcilar Medical Bulletin (2023) Vol. 8, Iss. 3, pp. 317-324
Open Access
Page 1

Scroll to top